GOLDMAN SACHS GROUP INC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 26 filers reported holding TRINITY BIOTECH PLC in Q3 2020. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q2 2021$32,000
-63.2%
10,937
-52.0%
0.00%
Q4 2020$87,000
-33.1%
22,794
-61.7%
0.00%
Q2 2020$130,000
-49.2%
59,463
+38.4%
0.00%
Q1 2017$256,000
-16.1%
42,972
-2.5%
0.00%
Q4 2016$305,00044,0780.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 739,669$13,514,0006.33%
ACK Asset Management 749,867$13,700,0004.92%
CASTLEROCK ASSET MANAGEMENT INC 26,751$489,0004.12%
GOLDMAN CAPITAL MANAGEMENT INC 309,297$5,651,0002.83%
Paradice Investment Management LLC 348,686$6,370,0001.66%
Park West Asset Management LLC 600,770$10,976,0001.62%
Adirondack Research & Management Inc. 220,638$4,031,0001.50%
RK Capital 375,043$6,852,0001.40%
KEANE CAPITAL MANAGEMENT INC 70,000$1,279,0001.23%
CARDINAL CAPITAL MANAGEMENT LLC /CT 953,618$17,423,0001.08%
View complete list of TRINITY BIOTECH PLC shareholders